Lower Antibody Levels In Bloodstream, Younger Age Associated With Greater Infection Risk In People With MS Receiving Ocrelizumab, Study Indicates

Multiple Sclerosis News Today (5/24, Bryson) reports researchers found “lower antibody levels in the bloodstream and younger age are associated with a greater likelihood of infection in people with multiple sclerosis (MS) receiving Ocrevus (ocrelizumab) t...